Orgenesis Inc. Files 8-K with Financials
Ticker: ORGS · Form: 8-K · Filed: Aug 29, 2024 · CIK: 1460602
| Field | Detail |
|---|---|
| Company | Orgenesis INC. (ORGS) |
| Form Type | 8-K |
| Filed Date | Aug 29, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-statements, disclosure
TL;DR
Orgenesis Inc. dropped an 8-K with financials on 8/29. Check it out.
AI Summary
Orgenesis Inc. filed an 8-K on August 29, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's operations and financial status as of August 29, 2024. Orgenesis Inc. is incorporated in Nevada and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides an update on Orgenesis Inc.'s financial condition and regulatory disclosures, which is crucial for investors to assess the company's performance and outlook.
Risk Assessment
Risk Level: medium — The filing is a routine 8-K with financial statements and disclosures, but the nature of the pharmaceutical sector and the company's specific financial health could introduce medium risk.
Key Players & Entities
- Orgenesis Inc. (company) — Registrant
- August 29, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 2834 (industry_code) — Standard Industrial Classification (Pharmaceutical Preparations)
- 20271 Goldenrod Lane, Germantown, MD 20876 (address) — Principal executive offices
- (480) 659-6404 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by Orgenesis Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits as of August 29, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on August 29, 2024.
In which state is Orgenesis Inc. incorporated?
Orgenesis Inc. is incorporated in Nevada.
What is the Standard Industrial Classification code for Orgenesis Inc. and what does it represent?
The Standard Industrial Classification code for Orgenesis Inc. is 2834, which represents Pharmaceutical Preparations.
What is the principal executive office address for Orgenesis Inc.?
The principal executive office address for Orgenesis Inc. is 20271 Goldenrod Lane, Germantown, MD 20876.
Filing Stats: 640 words · 3 min read · ~2 pages · Grade level 12.1 · Accepted 2024-08-29 08:30:47
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 493KB
- ex99-1_002.jpg (GRAPHIC) — 1657KB
- ex99-1_003.jpg (GRAPHIC) — 835KB
- ex99-1_004.jpg (GRAPHIC) — 849KB
- ex99-1_005.jpg (GRAPHIC) — 746KB
- ex99-1_006.jpg (GRAPHIC) — 744KB
- ex99-1_007.jpg (GRAPHIC) — 949KB
- ex99-1_008.jpg (GRAPHIC) — 959KB
- ex99-1_009.jpg (GRAPHIC) — 1524KB
- ex99-1_010.jpg (GRAPHIC) — 680KB
- ex99-1_011.jpg (GRAPHIC) — 1070KB
- ex99-1_012.jpg (GRAPHIC) — 1196KB
- ex99-1_013.jpg (GRAPHIC) — 1065KB
- ex99-1_014.jpg (GRAPHIC) — 1175KB
- ex99-1_015.jpg (GRAPHIC) — 778KB
- ex99-1_016.jpg (GRAPHIC) — 849KB
- ex99-1_017.jpg (GRAPHIC) — 791KB
- ex99-1_018.jpg (GRAPHIC) — 944KB
- 0001493152-24-034298.txt ( ) — 24019KB
- orgs-20240829.xsd (EX-101.SCH) — 3KB
- orgs-20240829_lab.xml (EX-101.LAB) — 33KB
- orgs-20240829_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. 99.1 Orgenesis Inc. Investor Presentation dated August 29, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: August 29, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary